---
title: "SWANBIO THERAPEUTICS LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/424ddea0-a606-52f1-abd8-c1c439be1f4f
json: https://whiteintel.dev/api/public/dossier/424ddea0-a606-52f1-abd8-c1c439be1f4f
identifier: oo:GB-COH-10942620
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# SWANBIO THERAPEUTICS LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-10942620`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/424ddea0-a606-52f1-abd8-c1c439be1f4f  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/424ddea0-a606-52f1-abd8-c1c439be1f4f  

## Ownership & control

### Owners / controllers

- **SPUR THERAPEUTICS HOLDINGS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/72ad03df-675f-5729-9f5a-d4dfc0b779b8
- **Rachel Lynn Salzman** (beneficial owner) — 50% — https://whiteintel.dev/entity/0d730a8c-e0d6-5dec-baf2-b8e1c8c490bf
- **Florian Sebald Eichler** (beneficial owner) — 50% — https://whiteintel.dev/entity/99b8e74c-9f9f-5ed9-b8bb-1dae53d1665d
- **Karen Fran Kozarsky** (beneficial owner) — 50% — https://whiteintel.dev/entity/d8475e1c-05b8-55ab-8b90-0566bbe586a0
- **Syncona Limited** (beneficial owner) — 62.5% — https://whiteintel.dev/entity/469c21c8-5340-404b-bed0-49a97f8dde35
- **SPUR THERAPEUTICS HOLDINGS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/72ad03df-675f-5729-9f5a-d4dfc0b779b8
- **Rachel Lynn Salzman** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/5ec801a3-7c75-4027-a2da-6305038cfd90
- **Florian Sebald Eichler** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/67dd9bcd-c531-47f4-ab6d-31a908019bd0
- **Karen Fran Kozarsky** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/0e6b3323-6301-45cb-bb44-cb60b760f644

### UBO chain (walk to the ultimate owner)

A **10-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `10942620`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2017-09-01
- **Registered office:** Sycamore House, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2BP, England
- **SIC:** 72110

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/10942620
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/10942620

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **SWANBIO THERAPEUTICS LIMITED** — https://whiteintel.dev/entity/424ddea0-a606-52f1-abd8-c1c439be1f4f · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **SWANBIO THERAPEUTICS LIMITED**. Human view: https://whiteintel.dev/entity/424ddea0-a606-52f1-abd8-c1c439be1f4f · Structured JSON: https://whiteintel.dev/api/public/dossier/424ddea0-a606-52f1-abd8-c1c439be1f4f._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._